Search

everythinglearnresearchcommunity

for

Search:↓

Frontal Fibrosing Alopecia is a poorly understood condition that is hard to treat and causes distressing hair loss.

Colored hair-thickening fibers can help hide hair loss in some people with Epidermolysis Bullosa but may cause scalp irritation.

Women who lost hair from childhood head radiation are more likely to face mental health issues than men.

Targeting the protein Caveolin-1 might help treat a type of scarring hair loss called Frontal Fibrosing Alopecia.

Higher social status is linked to earlier diagnosis and better treatment results for Frontal Fibrosing Alopecia in women.

Females are more affected by immune-related skin diseases, needing targeted health interventions.

Alopecia significantly impacts mental health and quality of life, requiring psychological support.

Personality traits significantly affect the onset, progression, and psychological impact of alopecia areata.

Psychological stress can affect skin health and disease progression.

Cancer survivors need better skin care to improve their quality of life.

Mesotherapy might help with hair growth in androgenic alopecia, but more research is needed.

Diffuse lichen planopilaris greatly reduces quality of life.

Spiritual well-being improves quality of life for Palestinian women with breast cancer.

Alopecia is caused by various factors, and new treatments like gene editing and regenerative medicine offer hope for personalized hair regrowth solutions.

Exosome therapy from treated stem cells may help reduce inflammation and promote hair regrowth in alopecia.

Adaptive coping reduces PCOS symptoms, while maladaptive coping worsens them.

Early-onset AGA shows different hair and metabolic characteristics compared to normal-onset AGA.

Multimedia education greatly improves women's knowledge and management of PCOS.

Alopecia causes significant emotional distress and psychological issues, requiring combined skin and mental health treatment.

Lower hardiness and resilience in mixed alopecia patients may predict more psychological distress.

Including ineffective or unsafe doses in reviews can lead to misleading conclusions about alopecia areata treatments.

Alopecia areata affects life quality differently based on its severity.

Black patients are underrepresented in alopecia research, highlighting the need for more inclusive studies.

Photobiomodulation improves the quality of life for people with hair loss.

Psoriasis patients are more likely to experience maladaptive daydreaming.

ADAM17 could be a potential target for treating PCOS.

People with skin conditions like psoriasis and eczema have higher anxiety levels.

People with hidradenitis suppurativa are more likely to have bipolar disorder than those with psoriasis or without skin conditions.

Low-Level Light Therapy improves quality of life more for women than men with hair loss.

The Middle East and Africa need better data, treatment consensus, and support for Alopecia Areata.